Cassava Sciences Inc vs iShares TIPS Bond ETF — how do they compare? Cassava Sciences Inc trades at $1.07 (market cap $53.14M), while iShares TIPS Bond ETF trades at $107.98. Which is the better fit depends on your goals.
| FLNA | TIP | |
|---|---|---|
Market Cap | $53.14M | — |
Sector | Health | Fixed Income |
52-Week High | $4.64 | $112.20 |
52-Week Low | $1.09 | $107.91 |
Enterprise Value | -$33.43M | — |
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
TIP is currently trading at $107.95, showing minimal daily movement with a slight decline of 0.06%. Technical indicators present a bearish picture, with moving averages signaling strong selling pressure, though oscillators like the RSI suggest potential oversold conditions. The company has announced upcoming dividend payments totaling $2.34 for 2026, providing income for shareholders. Financial ratios remain undisclosed in the current data snapshot, requiring further fundamental analysis.
The outlook for TIP appears cautious amid broader bond market volatility and uncertainty around Federal Reserve policy. Investment opportunities center on the attractive dividend yield, while risks include interest rate sensitivity and potential valuation pressure if bond yields continue rising. Market sentiment reflects heightened focus on fixed income dynamics as investors navigate inflationary pressures.
Trailing returns across standard periods
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →TIP is the flagship ETF for U.S. Treasury Inflation-Protected Securities (TIPS). It tracks an index of government bonds whose principal value adjusts based on the Consumer Price Index (CPI), providing a direct hedge against rising inflation.
Read more on TIP →